Literature DB >> 18419150

Hepatocystin is not secreted in cyst fluid of hepatocystin mutant polycystic liver patients.

Esmé Waanders1, Anke L L Lameris, Huub J M Op den Camp, Wendy Pluk, Jolein Gloerich, Simon P Strijk, Joost P H Drenth.   

Abstract

Autosomal dominant polycystic liver disease (PCLD) is characterized by multiple liver cysts and is caused by mutations in PRKCSH (hepatocystin). Mechanisms of cystogenesis are unknown, but previous studies have shown that hepatocystin is secreted in vitro. The goal of this study was to determine the fate of hepatocystin in vivo. Using immunoprecipitation, we determined that mutant hepatocystin is secreted from both apical and basolateral cell surface of MDCK cells stably transfected with mutant hepatocystin. Analysis of 60 cyst fluid samples from polycystic livers using Western blot, MALDI-TOF MS or nLC-MS/MS did not detect hepatocystin in liver cyst fluid. We did identify 163 ubiquitous serum proteins. No paracrine or autocrine factors were recognized. Although cyst fluids vary greatly in protein concentration, a PCLD specific protein pattern was not established. In conclusion, hepatocystin is not secreted in PCLD liver cyst fluid, suggesting that mutant hepatocystin is either not produced or degraded intracellularly. PCLD cysts develop from intralobular bile ductules and cyst fluid mainly contains common serum proteins comparable to that of other polycystic diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419150     DOI: 10.1021/pr8000282

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  4 in total

Review 1.  Cholangiociliopathies: genetics, molecular mechanisms and potential therapies.

Authors:  Tatyana Masyuk; Anatoliy Masyuk; Nicholas LaRusso
Journal:  Curr Opin Gastroenterol       Date:  2009-05       Impact factor: 3.287

2.  PRKCSH genetic mutation was not found in Taiwanese patients with polycystic liver disease.

Authors:  An-Ming Yang; Shou-Chuan Shih; Cheng-Hsin Chu; Tsang-En Wang; Wei-Shiung Yang
Journal:  Dig Dis Sci       Date:  2009-03-24       Impact factor: 3.199

3.  JNK signaling prevents biliary cyst formation through a CASPASE-8-dependent function of RIPK1 during aging.

Authors:  Katrin Müller; Hanna Honcharova-Biletska; Christiane Koppe; Michèle Egger; Lap Kwan Chan; Anne T Schneider; Lena Küsgens; Friederike Böhm; Yannick Boege; Marc E Healy; Johannes Schmitt; Sarah Comtesse; Mirco Castoldi; Christian Preisinger; Marta Szydlowska; Enrico Focaccia; Nadine T Gaisa; Sven H Loosen; Simone Jörs; Frank Tacke; Christoph Roderburg; Verena Keitel; Johannes G Bode; Peter Boor; Roger J Davis; Thomas Longerich; Fabian Geisler; Mathias Heikenwalder; Achim Weber; Mihael Vucur; Tom Luedde
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 11.205

Review 4.  Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.

Authors:  Wybrich R Cnossen; Joost P H Drenth
Journal:  Orphanet J Rare Dis       Date:  2014-05-01       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.